Joe Manchin stalled and killed the Build Back Better bill under pressure from big business. He could now support a compromise budget with drug pricing reforms, but the pharmaceutical industry is doing everything it can to make sure he doesn't.
A trove of documents published as part of a legal settlement offers an unvarnished look inside the financial relationships between pharmaceutical companies and the medical community — from the perspective of drug companies themselves.
If clinics that provide abortion shut down, women who can't travel to other states may turn to telehealth prescriptions or underground networks to obtain abortion pills, making that method of ending a pregnancy even more common.